Latest California Healthline Stories
Insurance companies profit from government contracts but are subject to little oversight of how they spend the money or care for patients. The expansion of Medicaid under the Affordable Care Act has only exacerbated the problem.
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
Sen. Ed Hernandez is in a public spat with the Indianapolis drugmaker over the company’s refusal to heed a state law requiring advance notice — and justification — of large drug price hikes. The company says it is awaiting a court decision on the law’s constitutionality.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
In a major coup for the beverage industry, California lawmakers agreed to ban cities and counties from adopting soda taxes for the next 12 years. In exchange, the beverage industry agreed to pull an initiative off the November ballot that, if passed, would have made it much harder for local governments to raise taxes.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
On April 1, Medicare launched a major initiative — a diabetes prevention program for seniors and people with serious disabilities— that is available in only a few cities.
A Bay Area public health campaign harnesses the power of poetry to confront the root causes of a diabetes epidemic that is disproportionately hitting minority youth and those from low-income homes.